Xarelto Approved for Atrial Fib Patients
The FDA has approved Janssen's Xarelto to prevent stroke in patients with atrial fibrillation -- with a strong black box warning.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
